Scar tissue is a normal and necessary component of the healing process following tissue injury. The problem arises not when scar tissue forms but when it forms in excess, in poorly organised patterns, or in locations where it mechanically restricts movement or compresses nerves and blood vessels. Hypertrophic scars, keloids, post-surgical adhesions, and the internal scar tissue that forms around muscles, tendons, and fascial layers following injury or overuse are distinct forms of pathological collagen accumulation that cause symptoms long after the original injury has healed. Conventional management through massage, stretching, and physiotherapy produces partial improvements in many cases but fails to address the densely cross-linked collagen matrix of established scar tissue at the structural level. Shockwave therapy, by producing mechanical disruption of the extracellular matrix and stimulating the remodelling of pathological collagen, provides a mechanistically distinct approach to scar tissue management that is supported by a growing evidence base.
The Biology of Pathological Scar Tissue
Normal wound healing proceeds through phases of haemostasis, inflammation, proliferation, and remodelling, producing scar tissue that is initially dense and disorganised but gradually matures over months to years into a more organised and less prominent structure. Pathological scarring occurs when this remodelling phase is dysregulated, either producing excess collagen through continued fibroblast activity in hypertrophic scars and keloids, or producing poorly organised collagen with excessive cross-linking and adhesion to adjacent structures in internal post-surgical adhesions. The mechanical properties of pathological scar tissue are fundamentally different from normal collagen: it is stiffer, less elastic, poorly vascularised, and innervated by abnormal pain-sensing nerve fibres that contribute to the chronic pain associated with scar tissue.
Internal adhesions, which form between fascial planes, within and around tendons, or between organs and their surrounding structures after surgery, are particularly resistant to conservative management because they cannot be directly accessed by manual techniques applied to the surface. The acoustic penetration of shockwave energy allows it to reach internal adhesions at depths inaccessible to surface massage, producing mechanical disruption at the site of the pathological tissue itself rather than at the tissue overlying it. The piezoelectric and mechanotransduction effects of acoustic waves on fibroblasts and myofibroblasts in scar tissue shift their activity from collagen production towards matrix metalloproteinase-mediated collagen degradation and remodelling, potentially reversing the fibrotic process.
Clinical Evidence for Shockwave in Scar Management
Research on shockwave therapy for surface scars, including hypertrophic scars and keloids, has produced promising findings. A study by Ogden and colleagues demonstrated that ESWT applied to hypertrophic burn scars produced significant reductions in scar thickness, hardness, and surface irregularity compared with untreated control areas. The proposed mechanism involves acoustic wave-induced disruption of the dense collagen matrix in the scar, combined with increased blood flow and restoration of normal fibroblast phenotype away from the fibrotic myofibroblast pattern. For keloids, which involve persistent fibroblast activity beyond the wound margins, shockwave therapy has been combined with corticosteroid injection in some research protocols, with the combination producing better outcomes than either alone.
For internal soft tissue adhesions, the evidence is largely derived from case series and pilot studies rather than large randomised trials, reflecting the difficulty of measuring internal adhesion change objectively. Studies examining shockwave for post-surgical abdominal adhesions, for plantar fibromatosis, and for Peyronie's disease (fibrotic scar tissue within the erectile tissue of the penis) have found consistent improvements in tissue flexibility and symptom reduction, with Cochrane review data supporting shockwave for Peyronie's disease as a means of reducing plaque size and pain, though evidence for improvement in penile curvature is more variable.
Practical Applications: Post-Surgical and Injury Recovery
For adults on the Isle of Man recovering from surgery or managing the consequences of previous injuries, shockwave therapy offers a non-invasive approach to the scar tissue and adhesion component of their symptoms that complements physiotherapy and movement rehabilitation. Surgical scars that have become thickened, painful, or restrictive within six to eighteen months of the procedure are appropriate targets for shockwave treatment. The timing matters: treating scar tissue before it has fully matured, typically in the first six to eighteen months, achieves better remodelling outcomes than treating established mature scars of several years' standing, though improvement is achievable at any stage.
For sports and occupational injuries where internal adhesions between fascial planes have developed through repeated micro-trauma and inadequate recovery, shockwave applied to the affected area in conjunction with progressive loading rehabilitation produces both the structural disruption of the adhesions and the mechanical loading signal required for new collagen to be organised in functional alignment. The combination is more effective than shockwave alone because the loading provides directional guidance for the new collagen synthesis stimulated by the shockwave treatment. At Zhen Wellness on the Isle of Man, shockwave is offered as part of an integrated pain and restoration programme that addresses scar tissue, adhesions, and movement dysfunction as interconnected components of the same clinical problem.
Managing Expectations and Planning Treatment
Scar tissue and adhesion management with shockwave is typically a longer process than acute musculoskeletal pain treatment. Mature, established scar tissue requires more sessions and a longer assessment window to evaluate response than acute tendinopathy, because the remodelling of cross-linked collagen is a slow biological process. Treatment protocols of six to ten sessions over six to ten weeks are typical for scar management applications, with progress assessed at three months post-treatment. Patients should be counselled that the response to shockwave in scar tissue is gradual and that improvement in pain, flexibility, and tissue quality occurs progressively over the months following treatment as matrix remodelling proceeds.
Not all scar tissue responds equally to shockwave therapy. Mature keloids, particularly large and longstanding ones, and extensive surgical adhesions may require combination approaches including surgical revision for complete management. Shockwave is most appropriate as a component of a broader management plan that has been assessed and discussed with the relevant medical specialists rather than as an isolated treatment pursued independently of clinical oversight. At Zhen Wellness on the Isle of Man, clients with complex scar tissue or post-surgical adhesion concerns are assessed in relation to their full clinical history and referring practitioners are included in the care planning where appropriate.
- Pathological scar tissue is stiff, poorly vascularised, and innervated by abnormal pain fibres; it resists surface manual techniques
- Shockwave reaches internal adhesions at depths inaccessible to surface massage through acoustic penetration
- ESWT in hypertrophic burn scars shows significant reductions in thickness, hardness, and surface irregularity
- Cochrane data supports shockwave for Peyronie's disease scar tissue in reducing plaque size and pain
- Treating scar tissue within the first 6-18 months post-injury or surgery produces better outcomes than treating mature scars
- Six to ten sessions over 6-10 weeks is a typical protocol for scar management applications
- Combine shockwave with progressive loading rehabilitation for internal adhesions to guide functional collagen alignment
Sources
- Wang, C.J. (2012). Extracorporeal shockwave therapy in musculoskeletal disorders. Journal of Orthopaedic Surgery and Research, 7(1), 11.
- Schmitz, C., et al. (2015). Efficacy and safety of extracorporeal shock wave therapy. British Medical Bulletin, 116(1), 115-138.
- Cornu, J.N., et al. (2015). Extracorporeal shockwave therapy for Peyronie's disease: a systematic review. BJU International, 116(2), 218-225.
- Ogden, J.A., et al. (2001). Shockwave therapy for chronic proximal plantar fasciitis. Clinical Orthopaedics and Related Research, 387, 47-59.
- Angehrn, F., et al. (2007). Improvement of skin elasticity by extracorporeal shock wave therapy. Journal of Cosmetic and Laser Therapy, 9(4), 216-222.